4-(1H-Pyrazol-1-yl)benzaldehyde → (2E)-3-[6-(1H-Pyrazol-1-yl)-2-pyridinyl]-2-propenal
Reaction equation
[N:1]1([C:6]2[N:11]=[C:10]([CH:12]=O)[CH:9]=[CH:8][CH:7]=2)[CH:5]=[CH:4][CH:3]=[N:2]1.N1(C2C=C[C:22]([CH:23]=[O:24])=CC=2)C=CC=N1>>[N:1]1([C:6]2[N:11]=[C:10](/[CH:12]=[CH:22]/[CH:23]=[O:24])[CH:9]=[CH:8][CH:7]=2)[CH:5]=[CH:4][CH:3]=[N:2]1Participants
3
Procedure
The title compound was prepared by a procedure analogous to Reference Example 30 by substituting 6-(1H-pyrazol-1-yl)-2-pyridinecarboxaldehyde (prepared as described in J. Med. Chem. 1998, 41, 5070) for the 4-(1H-pyrazol-1-yl)-benzaldehyde of Reference Example 30. MS 200 (M+H)+.
Sources & evidence
- ORD record
- ord-2f13c7f520be41dfb4bc8b7d3ebbc67d
- Source dataset
- uspto-grants-2004_11
- Patent number
- US06825170B2
Reaction notes
Loading…